These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17709821)

  • 1. Is MR-guided attenuation correction a viable option for dual-modality PET/MR imaging?
    Zaidi H
    Radiology; 2007 Sep; 244(3):639-42. PubMed ID: 17709821
    [No Abstract]   [Full Text] [Related]  

  • 2. PET/MR images acquired with a compact MR-compatible PET detector in a 7-T magnet.
    Judenhofer MS; Catana C; Swann BK; Siegel SB; Jung WI; Nutt RE; Cherry SR; Claussen CD; Pichler BJ
    Radiology; 2007 Sep; 244(3):807-14. PubMed ID: 17709830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-modality PET/CT instrumentation-today and tomorrow.
    Lonsdale MN; Beyer T
    Eur J Radiol; 2010 Mar; 73(3):452-60. PubMed ID: 20096520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation correction for PET/MR: problems, novel approaches and practical solutions.
    Martinez-Möller A; Nekolla SG
    Z Med Phys; 2012 Dec; 22(4):299-310. PubMed ID: 22925653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical role of fusion imaging using PET, CT, and MR imaging.
    Zaidi H; Montandon ML; Alavi A
    Magn Reson Imaging Clin N Am; 2010 Feb; 18(1):133-49. PubMed ID: 19962098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-cost, small-animal shelf for simultaneously assessing several small animals with a whole-body PET scanner.
    Buchert R; de Wit M; Raabe A; Bohuslavizki KH; Schulte U; Mester J; Clausen M
    J Nucl Med Technol; 2000 Sep; 28(3):171-2. PubMed ID: 11001499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body imaging with PET/MRI.
    Gaa J; Rummeny EJ; Seemann MD
    Eur J Med Res; 2004 Jun; 9(6):309-12. PubMed ID: 15257872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/MRI: challenges, solutions and perspectives.
    Herzog H
    Z Med Phys; 2012 Dec; 22(4):281-98. PubMed ID: 22925652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous PET and NMR.
    Marsden PK; Strul D; Keevil SF; Williams SC; Cash D
    Br J Radiol; 2002 Nov; 75 Spec No():S53-9. PubMed ID: 12519736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
    Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
    Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coincidence imaging using 2 dual-head gamma-camera systems, with and without attenuation correction.
    Even-Sapir E; Yuzefovich B; Miller E; Bouhnik JP; Zak O; Lerman H; Lievshitz G; Levin C
    J Nucl Med Technol; 2004 Dec; 32(4):190-7. PubMed ID: 15576340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography/computed tomography: the current technology and applications.
    Mittra E; Quon A
    Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiopharmaceuticals in PET imaging.
    Duncan K
    J Nucl Med Technol; 1998 Dec; 26(4):228-34; quiz 242. PubMed ID: 9884933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
    Bredella MA; Caputo GR; Steinbach LS
    AJR Am J Roentgenol; 2002 Nov; 179(5):1145-50. PubMed ID: 12388489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission mammographic instrument: initial results.
    Murthy K; Aznar M; Bergman AM; Thompson CJ; Robar JL; Lisbona R; Loutfi A; Gagnon JH
    Radiology; 2000 Apr; 215(1):280-5. PubMed ID: 10751499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous reconstruction of activity and attenuation for PET/MR.
    Salomon A; Goedicke A; Schweizer B; Aach T; Schulz V
    IEEE Trans Med Imaging; 2011 Mar; 30(3):804-13. PubMed ID: 21118768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.
    Li M; Wu N; Liu Y; Zheng R; Liang Y; Zhang W; Zhao P
    Eur J Radiol; 2012 Aug; 81(8):1886-90. PubMed ID: 21511421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image-guided biopsy: what the interventional radiologist needs to know about PET/CT.
    Kobayashi K; Bhargava P; Raja S; Nasseri F; Al-Balas HA; Smith DD; George SP; Vij MS
    Radiographics; 2012; 32(5):1483-501. PubMed ID: 22977031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.
    Antoch G; Freudenberg LS; Beyer T; Bockisch A; Debatin JF
    J Nucl Med; 2004 Jan; 45 Suppl 1():56S-65S. PubMed ID: 14736836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET, CT, and MR imaging of extra-articular pigmented villonodular synovitis.
    Nguyen BD
    Clin Nucl Med; 2007 Jun; 32(6):493-5. PubMed ID: 17515768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.